[Skin changes as a result of targeted therapies in oncology patients: cutaneous side effects of targeted therapies in oncology patients].
The growing number of patients treated with modern targeted therapies that cause specific cutaneous side effects is drawing attention to the optimal management of these side effects. Experience to date has shown that good management allows the majority of patients to receive the treatment as planned. As a result of the link between dermatological side effects and the success of treatment than can be assumed to exist for many substances, interdisciplinary collaboration between dermatologists and professionals from other disciplines working in the field of oncology is becoming increasingly important.
Kähler
K C
KC
Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, 24105, Kiel, Deutschland. kckaehler@yahoo.de
Hauschild
A
A
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016503:Drug Delivery Systems / Q000009:adverse effects*; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D012867:Skin / Q000187:drug effects*
D000970:Antineoplastic Agents